title: Effect of dose and specific activity on tissue distribution of indium-111-pentetreotide in rats.
abstract: To increase the target-to-background ratio in receptor scintigraphy, we hypothesized that receptor scintigraphy is best performed using the lowest possible mass with the highest possible specific radioactivity of the radioligand.
  
  
  METHODS
  Rats were injected with 2 or 10 micrograms of unlabeled octreotide or 2 or 10 micrograms of 111In-pentetreotide. Scintigraphic images were then obtained from 10 min before to 20 min after the 111In injection.
  
  
  RESULTS
  In some instances, there was a significant increase in 111In uptake in somatostatin receptor-positive organs. In others, there was a significant decrease. Since no significant differences were found in background radioactivity in the percent dose uptake of 111In in receptor-negative organs, these data indicate that target-to-background ratios can be increased by the administration of nonradiolabeled peptides under select conditions.
  
  
  CONCLUSIONS
  The uptake of 111In-pentetreotide in somatostatin receptor-positive organs results in a tissue-specific bell-shaped function of the injected mass of the radiopharmaceutical. This curve may also apply to somatostatin receptor-positive tumors, the visualization of which may be enhanced by optimizing the mass of 111In-pentetreotide.
authors.affiliation: Department of Nuclear Medicine, University Hospital Dijkzigt, Rotterdam, The Netherlands.
authors.forename: W A
authors.initials: WA
authors.lastname: Breeman
authors.forename: D J
authors.initials: DJ
authors.lastname: Kwekkeboom
authors.forename: P P
authors.initials: PP
authors.lastname: Kooij
authors.forename: W H
authors.initials: WH
authors.lastname: Bakker
authors.forename: L J
authors.initials: LJ
authors.lastname: Hofland
authors.forename: T J
authors.initials: TJ
authors.lastname: Visser
authors.forename: G J
authors.initials: GJ
authors.lastname: Ensing
authors.forename: S W
authors.initials: SW
authors.lastname: Lamberts
authors.forename: E P
authors.initials: EP
authors.lastname: Krenning
mesh_terms: D000818:Animals; D007205:Indium Radioisotopes / Q000008:administration & dosage / Q000493:pharmacokinetics; D007275:Injections, Intravenous; D008297:Male; D015282:Octreotide; D051381:Rats; D017208:Rats, Wistar; D017481:Receptors, Somatostatin / Q000032:analysis; D013004:Somatostatin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D014018:Tissue Distribution
chemical_list: D007205:Indium Radioisotopes; D017481:Receptors, Somatostatin; D013004:Somatostatin; C081788:pentetreotide; D015282:Octreotide